Inventor
LIU BAI
US39 patents
⚠️ This page may combine multiple inventors who share the name “LIU BAI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALTOR BIOSCIENCE LLC
26 patentsUS10537615B2Jan 21, 2020
IL-15-based molecules and methods of use thereof
ALTOR BIOSCIENCE LLC23 citations98
US11679144B2Jun 20, 2023
IL-15-based molecules and methods of use thereof
ALTOR BIOSCIENCE LLC6 citations94
US11471511B2Oct 18, 2022
IL-15-based molecules and methods of use thereof
ALTOR BIOSCIENCE LLC13 citations94
US11173191B2Nov 16, 2021
IL-15-based molecules and methods of use thereof
ALTOR BIOSCIENCE LLC13 citations94
US11104716B2Aug 31, 2021
Multimeric IL-15 soluble fusion molecules and methods of making and using same
ALTOR BIOSCIENCE LLC12 citations94
US11046747B2Jun 29, 2021
Multimeric IL-15 soluble fusion molecules and methods of making and using same
ALTOR BIOSCIENCE LLC18 citations94
US10899821B2Jan 26, 2021
Method of treating neoplasia with a multimeric IL-15 soluble fusion molecule
ALTOR BIOSCIENCE LLC15 citations94
US11129883B2Sep 28, 2021
IL-15-based fusions to IL-12 and IL-18
ALTOR BIOSCIENCE LLC16 citations93
US11992516B2May 28, 2024
Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodies
ALTOR BIOSCIENCE LLC3 citations86
US11925676B2Mar 12, 2024
Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complex
ALTOR BIOSCIENCE LLC3 citations86
US11890323B2Feb 6, 2024
Method of treating cancer with composition comprising IL-15-based molecules and BCG
ALTOR BIOSCIENCE LLC3 citations86
US11845783B2Dec 19, 2023
Multimeric IL-15 soluble fusion molecules and methods of making and using same
ALTOR BIOSCIENCE LLC6 citations86
US11612645B2Mar 28, 2023
IL-15-based fusions to IL-12 and IL-18
ALTOR BIOSCIENCE LLC6 citations85
US11571470B2Feb 7, 2023
IL-15-based fusions to IL-12 and IL-18
ALTOR BIOSCIENCE LLC6 citations85
US11369679B2Jun 28, 2022
Multimeric IL-15-based molecules
ALTOR BIOSCIENCE LLC10 citations84
US11318201B2May 3, 2022
Multimeric IL-15-based molecules
ALTOR BIOSCIENCE LLC13 citations83
US12318432B2Jun 3, 2025
BCG and IL-15 based molecules
ALTOR BIOSCIENCE LLC0 citations73
US12268731B2Apr 8, 2025
Compositions comprising IL-15N72D-based molecules and bacillus calmette-guerin (BCG)
ALTOR BIOSCIENCE LLC0 citations73
US12186372B2Jan 7, 2025
IL-15-based molecules and methods of treating a neoplasia
ALTOR BIOSCIENCE LLC0 citations73
US12097244B2Sep 24, 2024
Methods of treating a neoplasia with IL-15-based molecules and CTLA-4 antibody
ALTOR BIOSCIENCE LLC0 citations73
US11975059B2May 7, 2024
IL-15-based fusions to IL-12 and IL-18
ALTOR BIOSCIENCE LLC2 citations72
US11872272B2Jan 16, 2024
IL-15-based fusions to IL-12 and IL-18
ALTOR BIOSCIENCE LLC1 citations72
US12371472B2Jul 29, 2025
Multimeric IL-15 soluble fusion molecules and methods of making and using same
ALTOR BIOSCIENCE LLC0 citations62
US12268732B2Apr 8, 2025
IL-15-based molecules with anti-CD20 antibody and methods of use
ALTOR BIOSCIENCE LLC0 citations62
US12233116B2Feb 25, 2025
IL-15-based fusions to IL-12 and IL-18
ALTOR BIOSCIENCE LLC0 citations62
US10844107B2Nov 24, 2020
HIV VPR-specific T-cell receptors
ALTOR BIOSCIENCE LLC0 citations48
ALTOR BIOSCIENCE CORP
7 patentsUS10358478B2Jul 23, 2019
Multimeric IL-15 soluble fusion molecules and methods of making and using same
ALTOR BIOSCIENCE CORP26 citations98
US10150805B2Dec 11, 2018
Multimeric IL-15 soluble fusion molecules and methods of making and using same
ALTOR BIOSCIENCE CORP44 citations98
US9925247B2Mar 27, 2018
IL-15-based molecules and methods of use thereof
ALTOR BIOSCIENCE CORP37 citations98
US9428573B2Aug 30, 2016
Multimeric IL-15 soluble fusion molecules and methods of making and using same
ALTOR BIOSCIENCE CORP56 citations98
US9328159B2May 3, 2016
Multimeric IL-15 soluble fusion molecules and methods of using same
ALTOR BIOSCIENCE CORP54 citations98
US10865230B2Dec 15, 2020
Construction and characterization of multimeric IL-15-based molecules with CD3 binding domains
ALTOR BIOSCIENCE CORP21 citations94
US9714279B2Jul 25, 2017
HIV vpr-specific T-cell receptors
ALTOR BIOSCIENCE CORP1 citations60